Detalles de la búsqueda
1.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875670
2.
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
Proc Natl Acad Sci U S A
; 110(24): 9845-50, 2013 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23697367
3.
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age.
Immun Ageing
; 11(1): 3, 2014 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24498974
4.
Online Home-Based Physical Activity Counteracts Changes of Redox-Status Biomarkers and Fitness Profiles during Treatment Programs in Postsurgery Female Breast Cancer Patients.
Antioxidants (Basel)
; 12(5)2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37238004
5.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
J Transl Med
; 10: 223, 2012 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23148845
6.
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates.
Immun Ageing
; 9(1): 24, 2012 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23148571
7.
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy.
Cancer Immunol Immunother
; 60(10): 1373-81, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21739118
8.
Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer.
Clin Dev Immunol
; 2011: 819724, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22235223
9.
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer.
Curr Oncol
; 28(3): 1957-1961, 2021 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34073827
10.
Beyond BRCA1 and BRCA2: Deleterious Variants in DNA Repair Pathway Genes in Italian Families with Breast/Ovarian and Pancreatic Cancers.
J Clin Med
; 9(9)2020 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32957588
11.
Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer.
World J Gastrointest Oncol
; 11(2): 117-138, 2019 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30788039
12.
Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline.
Oncotarget
; 9(72): 33648-33655, 2018 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30263092
13.
A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
Gen Hosp Psychiatry
; 29(5): 461-3, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17888816
14.
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes.
Anticancer Res
; 37(5): 2633-2639, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28476838
15.
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy.
Curr Drug Targets
; 18(4): 485-495, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27397062
16.
Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?
Cancer Biother Radiopharm
; 21(5): 468-87, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17105420
17.
The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer.
Cancer Biother Radiopharm
; 21(5): 443-67, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17105419
18.
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy.
Cancer Biother Radiopharm
; 21(5): 488-505, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17105421
19.
CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Transpl Immunol
; 12(1): 49-61, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-14551032
20.
IFNbeta-1a treatment and reestablishment of Th1 regulation in MS patients: dose effects.
Clin Neuropharmacol
; 27(6): 258-69, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15613929